Biosimilars in the United States: Unraveling the Path Forward and Lessons Learned from Europe

June 28, 2017 at 2:00pm3:00pm

Webinar

In this webinar, presenter Sapna Palla, Partner in the Life Sciences Intellectual Property Group, will discuss:

  • The pitfalls in the nascent United States biosimilar regulations.
  • Recent developments and issues before the Federal Circuit and United States Supreme Court.
  • Key differences compared to the European regime and lessons learned.
  • Practical tips and considerations for companies in the biosimilars space operating both in the United States and internationally.

 To register for this event, click here.